Investigations on a clinically and functionally unusual and novel germline p53 mutation
✍ Scribed by Rutherford, J; Chu, C E; Duddy, P M; Charlton, R S; Chumas, P; Taylor, G R; Lu, X; Barnes, D M; Camplejohn, R S
- Book ID
- 109997234
- Publisher
- Nature Publishing Group
- Year
- 2002
- Tongue
- English
- Weight
- 157 KB
- Volume
- 86
- Category
- Article
- ISSN
- 0007-0920
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Germline mutations in the __p53__ tumor suppressor gene have been identified in patients with Li‐Fraumeni syndrome (LFS) and patients with Li‐Fraumeni‐like syndrome (LFL). However, to date, germline __p53__ mutations in patients not fulfilling the criteria of LFS or LFL have been report
Multiple endocrine neoplasia (MEN) syndromes are characterized by tumors involving two or more endocrine glands. Two MEN syndromes have long been known: MEN1 and MEN2, caused by germline mutations in __MEN1__ or __RET__, respectively. Recently, mutations in __CDKN1B__, encoding the cyclin-dependent